Unknown

Dataset Information

0

A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.


ABSTRACT: Zinc transporter eight (SLC30A8) is a major target of autoimmunity in human type 1A diabetes and is implicated in type 2 diabetes in genome-wide association studies. The type 2 diabetes nonsynonymous single nucleotide polymorphism (SNP) affecting aa(325) lies within the region of highest ZnT8 autoantibody (ZnT8A) binding, prompting an investigation of its relationship to type 1 diabetes.ZnT8A radioimmunoprecipitation assays were performed in 421 new-onset type 1 diabetic Caucasians using COOH-terminal constructs incorporating the known human aa(325) variants (Trp, Arg, and Gln). Genotypes were determined by PCR-based SNP analysis. RESULTS-Sera from 224 subjects (53%) were reactive to Arg(325) probes, from 185 (44%) to Trp(325)probes, and from 142 (34%) to Gln(325)probes. Sixty subjects reacted only with Arg(325) constructs, 31 with Trp(325) only, and 1 with Gln(325) only. The restriction to either Arg(325) or Trp(325) corresponded with inheritance of the respective C- or T-alleles. A strong gene dosage effect was also evident because both Arg- and Trp-restricted ZnT8As were less prevalent in heterozygous than homozygous individuals. The SLC30A8 SNP allele frequency (75% C and 25% T) varied little with age of type 1 diabetes onset or the presence of other autoantibodies.The finding that diabetes autoimmunity can be defined by a single polymorphic residue has not previously been documented. It argues against ZnT8 autoimmunity arising from molecular mimicry and suggests a mechanistic link between the two major forms of diabetes. It has implications for antigen-based therapeutic interventions because the response to ZnT8 administration could be protective or immunogenic depending on an individual's genotype.

SUBMITTER: Wenzlau JM 

PROVIDER: S-EPMC2551679 | biostudies-literature | 2008 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.

Wenzlau Janet M JM   Liu Yu Y   Yu Liping L   Moua Ong O   Fowler Kimberly T KT   Rangasamy Sampathkumar S   Walters Jay J   Eisenbarth George S GS   Davidson Howard W HW   Hutton John C JC  

Diabetes 20080630 10


<h4>Objective</h4>Zinc transporter eight (SLC30A8) is a major target of autoimmunity in human type 1A diabetes and is implicated in type 2 diabetes in genome-wide association studies. The type 2 diabetes nonsynonymous single nucleotide polymorphism (SNP) affecting aa(325) lies within the region of highest ZnT8 autoantibody (ZnT8A) binding, prompting an investigation of its relationship to type 1 diabetes.<h4>Research design and methods</h4>ZnT8A radioimmunoprecipitation assays were performed in  ...[more]

Similar Datasets

| S-EPMC2517168 | biostudies-literature
| S-EPMC3784536 | biostudies-literature
| S-EPMC4298399 | biostudies-literature
| S-EPMC8244513 | biostudies-literature
| S-EPMC2040407 | biostudies-other
| S-EPMC3170126 | biostudies-literature
| S-EPMC3664522 | biostudies-literature
| S-EPMC4079946 | biostudies-literature
| S-EPMC4527121 | biostudies-literature
| S-EPMC6699160 | biostudies-literature